CN: 32-1845/R
ISSN: 2095-6975
Pooja Bhardwaj, Deepa Khanna. Green tea catechins:defensive role in cardiovascular disorders[J]. 中国天然药物英文, 2013, 11(4): 345-353

Green tea catechins:defensive role in cardiovascular disorders

Pooja Bhardwaj, Deepa Khanna
Cardiovascular Pharmacology Division, Department of Pharmacology, Rajendra Institute of Technology and Sciences, Sirsa, India
Green tea,Camellia sinensis(Theaceae),a major source of flavonoids such as catechins,has recently shown multiple cardiovascular health benefits through various experimental and clinical studies.These studies suggest that green tea catechins prevent the incidence of detrimental cardiovascular events,and also lower the cardiovascular mortality rate.Catechins present in green tea have the ability to prevent atherosclerosis,hypertension,endothelial dysfunction,ischemic heart diseases,cardiomyopathy,cardiac hypertrophy and congestive heart failure by decreasing oxidative stress,preventing inflammatory events,reducing platelet aggregation and halting the proliferation of vascular smooth muscle cells.Catechins afford an anti-oxidant effect by inducing anti-oxidant enzymes,inhibiting pro-oxidant enzymes and scavenging free radicals.Catechins present anti-inflammatory activity through the inhibition of transcriptional factor NF-κB-mediated production of cytokines and adhesion molecules.Green tea catechins interfere with vascular growth factors and thus inhibit vascular smooth muscle cell proliferation,and also inhibit thrombogenesis by suppressing platelet adhesion.Additionally,catechins could protect vascular endothelial cells and enhance vascular integrity and regulate blood pressure.In this review various experimental and clinical studies suggesting the role of green tea catechins against the markers of cardiovascular disorders and the underlying mechanisms for these actions are discussed.
关键词:    Green tea catechins    Reactive oxygen species    Vascular cell adhesion molecule-1    Nitric oxide    Cardiovascular disorders   
收稿日期: 2013-03-19
PDF(728 KB) Free
Pooja Bhardwaj 在本刊中的所有文章
Deepa Khanna 在本刊中的所有文章
[1] Graham HN.Green tea composition,consumption,and polyphenol chemistry[J].Prev Med,1992,21(3):334-350.
[2] Sang S,Lambert JD,Ho CT,et al.The chemistry and biotransformation of tea constituents[J].Pharmacol Res,2011,64(2):87-99.
[3] Cabrera C,Artacho R,Giménez R.Beneficial effects of green tea-a review[J].J Am Coll Nutr,2006,25(2):79-99.
[4] Balentine DA,Wiseman SA,Bouwens LC.The chemistry of tea flavonoids[J].Crit Rev Food Sci Nutr,1997,37(8):693-704.
[5] Henning SM,Fajardo-Lira C,Lee HW,et al.Catechin content of 18 teas and a green tea extract supplement correlates with the antioxidant capacity[J].Nutr Cancer,2003,45(2):226-235.
[6] Kimura M,Umegaki K,Kasuya Y,et al.The relation between single/double or repeated tea catechin ingestions and plasma antioxidant activity in humans[J].Eur J Clin Nutr,2002,56(12):1186-1193.
[7] Cabrera C,Giménez R,López MC.Determination of tea components with antioxidant activity[J].J Agric Food Chem,2003,51(15):4427-4435.
[8] Kuroda Y,Hara Y.Antimutagenic and anticarcinogenic activity of tea polyphenols[J].Mutat Res,1999,436(1):69-97.
[9] Isozaki T,Tamura H.Epigallocatechin gallate(EGCG) inhibits the sulfation of 1-naphthol in a human colon carcinoma cell line,Caco-2[J].Biol Pharm Bull,2001,24(9):1076-1078.
[10] Valcic S,Timmermann BN,Alberts DS,et al.Inhibitory effect of six green tea catechins and caffeine on the growth of four selected human tumor cell lines[J].Anticancer Drugs,1996,7(4):461-468.
[11] Lee IP,Kim YH,Kang MH,et al.Chemopreventive effect of green tea(Camellia sinensis) against cigarette smoke-induced mutations(SCE) in humans[J].J Cell Biochem Suppl,1997,27(1):68-75.
[12] Rizvi SI,Zaid MA.Intracellular reduced glutathione content in normal and type 2 diabetic erythrocytes:effect of insulin and(-)-epicatechin[J].J Physiol Pharmacol,2001,52(3):483-488.
[13] Nagao T,Komine Y,Soga S,et al.Ingestion of a tea rich in catechins leads to a reduction in body fat and malondialdehyde-modified LDL in men[J].Am J Clin Nutr,2005,81(1):122-129.
[14] WHO.World Health Statistics 2009[M].Geneva:World Health Organization,2009e.
[15] Kuriyama S,Shimazu T,Ohmori K,et al.Green tea consumption and mortality due to cardiovascular disease,cancer,and all causes in Japan:the Ohsaki study[J].JAMA 2006,296(10):1255-1265.
[16] Sasazuki S,Kodama H,Yoshimasu K,et al.Relation between green tea consumption and the severity of coronary atherosclerosis among Japanese men and women[J].Ann Epidemiol,2000,10(6):401-408.
[17] Hernández Figueroa TT,Rodríguez-Rodríguez E,Sánchez-Muniz FJ.The green tea,a good choice for cardiovascular disease prevention[J] Arch Latinoam Nutr,2004,54(4):380-394.
[18] Babu PV,Liu D.Green tea catechins and cardiovascular health:an update[J].Curr Med Chem,2008,15(18):1840-1850.
[19] Islam MA.Cardiovascular effects of green tea catechins:progress and promise[J].Recent Pat Cardiovasc Drug Discov,2012,7(2):88-99.
[20] Dhalla NS,Temsah RM,Netticadan T.Role of oxidative stress in cardiovascular diseases[J].J Hypertens,2000,18(6):655-673.
[21] Park J,Lee J,Choi C.Mitochondrial network determines intracellular ROS dynamics and sensitivity to oxidative stress through switching inter-mitochondrial messengers[J].PLoS One,2011,6(8):e23211.
[22] Paravicini TM,Touyz RM.NADPH oxidases,reactive oxygen species,and hypertension:clinical implications and therapeutic possibilities[J].Diabetes Care,2008,31(Suppl 2):S170-S180.
[23] Zinkevich NS,Gutterman DD.ROS-induced ROS release in vascular biology:redox-redox signaling[J].Am J Physiol Heart Circ Physiol,2011,301(3):H647-H653.
[24] Heim KE,Tagliaferro AR,Bobilya DJ.Flavonoid antioxidants:chemistry,metabolism and structure-activity relationships[J].J Nutr Biochem,2002,13(10):572-584.
[25] Yamabe N,Yokozawa T,Oya T,et al.Therapeutic potential of(-)-epigallocatechin 3-O-gallate on renal damage in diabetic nephropathy model rats[J].J Pharmacol Exp Ther,2006,319(1):228-236.
[26] Frei B,Higdon JV.Antioxidant activity of tea polyphenols in vivo:evidence from animal studies[J].J Nutr,2003,133(10):3275S-3284S.
[27] Agarwal A,Prasad R,Jain A.Effect of green tea extract(catechins) in reducing oxidative stress seen in patients of pulmonary tuberculosis on DOTS Cat I regimen[J].Phytomedicine,2010,17(1):23-27.
[28] Zheng J,Lee HC,Bin Sattar MM,et al.Cardioprotective effects of epigallocatechin-3-gallate against doxorubicininduced cardiomyocyte injury[J].Eur J Pharmacol,2011,652(1-3):82-88.
[29] Miura Y,Chiba T,Tomita I,et al.Tea catechins prevent the development of atherosclerosis in apoprotein E-deficient mice[J].J Nutr,2001,131(1):27-32.
[30] Libby P.Inflammation and cardiovascular disease mechanisms[J].Am J Clin Nutr,2006,83(2):456S-460S.
[31] Mayer K,Merfels M,Muhly-Reinholz M,et al.Omega-3 fatty acids suppress monocyte adhesion to human endothelial cells:role of endothelial PAF generation[J].Am J Physiol Heart Circ Physiol,2002,283(2):H811-H818.
[32] Gu L,Okada Y,Clinton SK,et al.Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice[J].Mol Cell,1998,2(2):275-281.
[33] Marui N,Offermann MK,Swerlick R,et al.Vascular cell adhesion molecule-1(VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells[J].J Clin Invest,1993,92(4):1866-1874.
[34] Kevil CG,Patel RP,Bullard DC.Essential role of ICAM-1 in mediating monocyte adhesion to aortic endothelial cells[J].Am J Physiol Cell Physiol,2001,281:C1442-C1447.
[35] Gerszten RE,Garcia-Zepeda EA,Lim YC,et al.MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions[J].Nature,1999,398(6729):718-723.
[36] Qiao JH,Tripathi J,Mishra NK,et al.Role of macrophage colony-stimulating factor in atherosclerosis:studies of osteopetrotic mice[J].Am J Pathol,1997,150(5):1687-1699.
[37] Brånén L,Hovgaard L,Nitulescu M,et al.Inhibition of tumor necrosis factor-alpha reduces atherosclerosis in apolipoprotein E knockout mice[J].Arterioscler Thromb Vasc Biol,2004,24(11):2137-2142.
[38] Lin YL,Lin JK.(-)-Epigallocatechin-3-gallate blocks the induction of nitric oxide synthase by down-regulating lipopolysaccharide-induced activity of transcription factor nuclear factor-kappa B[J].Mol Pharmacol,1997,52(3):465-472.
[39] Suzuki J,Ogawa M,Izawa A,et al.Dietary consumption of green tea catechins attenuate hyperlipidaemia-induced atherosclerosis and systemic organ damage in mice[J].Acta Cardiol,2005,60(3):271-276.
[40] Suzuki J,Ogawa M,Futamatsu H,et al.Tea catechins improve left ventricular dysfunction,suppress myocardial inflammation and fibrosis,and alter cytokine expression in rat autoimmune myocarditis[J].Eur J Heart Fail,2007,9(2):152-159.
[41] Ludwig A,Lorenz M,Grimbo N,Steinle F,et al.The tea flavonoid epigallocatechin-3-gallate reduces cytokine-induced VCAM-1 expression and monocyte adhesion to endothelial cells[J].Biochem Biophys Res Commun,2004,316:659-665.
[42] Liang OD,Kleibrink BE,Schuette-Nuetgen K,et al.Green tea epigallo-catechin-galleate ameliorates the development of obliterative airway disease[J].Exp Lung Res,2011,37(7):435-444.
[43] Aird WC.Phenotypic heterogeneity of the endothelium:I.Structure,function,and mechanisms[J].Circ Res,2007,100(2):158-173.
[44] Galley HF,Webster NR.Physiology of the endothelium[J].Br J Anaesth,2004,93(1):105-113.
[45] Schiffrin EL.A critical review of the role of endothelial factors in the pathogenesis of hypertension[J].J Cardiovasc Pharmacol,2001,38:S3-S6.
[46] Balakumar P,Chakkarwar VA,Krishan P,et al.Vascular endothelial dysfunction:a tug of war in diabetic nephropathy[J] ?Biomed Pharmacother,2009,63(3):171-179.
[47] Forstermann U,Munzel T.Endothelial nitric oxide synthase in vascular disease:from marvel to menace[J].Circulation,2006,113(13):1708-1714.
[48] Dimmeler S,Fleming I,Fisslthaler B,et al.Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation[J].Nature,1999,399(6736):601-605.
[49] Kobayashi T,Matsumoto T,Kamata K.The PI3-K/Akt pathway:roles related to alterations in vasomotor responses in diabetic model[J].J Smooth Muscle Res,2005,41(6):283-302.
[50] Hadi HAR,Carr CS,Al Suwaidi J.Endothelial dysfunction:cardiovascular risk factors,therapy,and outcome[J].Vasc Health Risk Manag,2005,1(3):183-198.
[51] Lorenz M,Wessler S,Follmann E,et al.A constituent of green tea,epigallocatechin-3-gallate,activates endothelial nitric oxide synthase by a phosphatidylinositol-3-OH-kinase-,cAMP-dependent protein kinase-,and Akt-dependent pathway and leads to endothelial-dependent vasorelaxation[J].J Biol Chem,2004,279(7):6190-6195.
[52] Potenza MA,Marasciulo FL,Tarquinio M,et al.EGCG,a green tea polyphenol,improves endothelial function and insulin sensitivity,reduces blood pressure,and protects against myocardial I/R injury in SHR[J].Am J Physiol Endocrinol Metab,2007,292(5):E1378-E1387.
[53] Mizugaki M,Ishizawa F,Yamazaki T,et al.Epigallocatechin gallate increases the prostacyclin production of bovine aortic endothelial cells[J].Prostaglandins Other Lipid Mediat,2000,62(2):157-164.
[54] Landim MB,Casella Filho A,Chagas AC.Asymmetric dimethylarginine(ADMA) and endothelial dysfunction:implications for atherogenesis[J].Clinics(Sao Paulo),2009,64(5):471-478.
[55] Tang WJ,Hu CP,Chen MF,et al.Epigallocatechin gallate preserves endothelial function by reducing the endogenous nitric oxide synthase inhibitor level[J].Can J Physiol Pharmacol,2006,84(2):163-171.
[56] Negishi H,Xu JW,Ikeda K,et al.Black and green tea polyphenols attenuate blood pressure increases in stroke-prone spontaneously hypertensive rats[J].J Nutr,2004,134(1):38-42.
[57] Ross R,Glomset JA.Atherosclerosis and the arterial smooth muscle cell:Proliferation of smooth muscle is a key event in the genesis of the lesions of atherosclerosis[J].Science,1973,180(4093):1332-1339.
[58] Schwartz SM,deBlois D,O'Brien ER.The intima.Soil for atherosclerosis and restenosis[J].Circ Res,1995,77(3):445-465.
[59] Visse R,Nagase H.Matrix metalloproteinases and tissue inhibitors of metalloproteinases:structure,function,and biochemistry[J].Circ Res,2003,92(8):827-839.
[60] Lindner V,Reidy MA.Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor[J].Proc Natl Acad Sci USA,1991,88(9):3739-3743.
[61] De Donatis A,Comito G,Buricchi F,et al.Proliferation versus migration in platelet-derived growth factor signaling:the key role of endocytosis[J].J Biol Chem,2008,283(29):19948-19956.
[62] Won SM,Park YH,Kim HJ,et al.Catechins inhibit angiotensin II-induced vascular smooth muscle cell proliferation via mitogen-activated protein kinase pathway[J].Exp Mol Med,2006,38(5):525-534.
[63] El Bedoui J,Oak MH,Anglard P,et al.Catechins prevent vascular smooth muscle cell invasion by inhibiting MT1-MMP activity and MMP-2 expression[J].Cardiovasc Res,2005,67(2):317-325.
[64] Kim CH,Moon SK.Epigallocatechin-3-gallate causes the p21/WAF1-mediated G(1)-phase arrest of cell cycle and inhibits matrix metalloproteinase-9 expression in TNF-alpha-induced vascular smooth muscle cells[J].Arch Biochem Biophys,2005,435(2):264-272.
[65] Ahn HY,Hadizadeh KR,Seul C,et al.Epigallocathechin-3 gallate selectively inhibits the PDGF-BB-induced intracellular signaling transduction pathway in vascular smooth muscle cells and inhibits transformation of sis-transfected NIH 3T3 fibroblasts and human glioblastoma cells(A172)[J].Mol Biol Cell,1999,10(4):1093-1104.
[66] Yuan X,Zhang Z,Gong K,et al.Inhibition of reactive oxygen species/extracellular signal-regulated kinases pathway by pioglitazone attenuates advanced glycation end products-induced proliferation of vascular smooth muscle cells in rats[J].Biol Pharm Bull,2011,34(5):618-623.
[67] Ouyang P,Peng WL,Xu DL,et al.Green tea polyphenols inhibit advanced glycation end product-induced rat vascular smooth muscle cell proliferation[J].Acad J First Med Coll PLA,2004,24(3):247-251.
[68] Yamamoto M,Acevedo-Duncan M,Chalfant CE,et al.Acute glucose-induced downregulation of PKC-betaII accelerates cultured VSMC proliferation[J].Am J Physiol Cell Physiol,2000,279(3):C587-C595.
[69] Yang J,Han Y,Sun H,et al.(-)-Epigallocatechin gallate suppresses proliferation of vascular smooth muscle cells induced by high glucose by inhibition of PKC and ERK1/2 signalings[J].J Agric Food Chem,2011,59(21):11483-11490.
[70] Jagroop IA,Kakafika AI,Mikhailidis DP.Platelets and vascular risk:an option for treatment[J].Curr Pharm Des,2007,13(16):1669-1683.
[71] Born GV.Platelets in thrombogenesis:Mechanism and inhibition of platelet aggregation[J].Ann Roy Coll Surg Engl,1965,36:200-206.
[72] Ueno M,Kodali M,Tello-Montoliu A,et al.Role of platelets and antiplatelet therapy in cardiovascular disease[J].J Atheroscler Thromb,2011,18(6):431-442.
[73] Kang WS,Lim IH,Yuk DY,et al.Antithrombotic activities of green tea catechins and(-)-epigallocatechin gallate[J].Thromb Res,1999,96(3):229-237.
[74] Yang JA,Choi JH,Rhee SJ.Effects of green tea catechin on phospholipase A2 activity and antithrombus in streptozotocin diabetic rats[J].J Nutr Sci Vitaminol(Tokyo),1999,45(3):337-346.
[75] Son DJ,Cho MR,Jin YR,et al.Antiplatelet effect of green tea catechins:a possible mechanism through arachidonic acid pathway[J].Prostagland Leukot Essent Fatty Acids,2004,71(1):25-31.
[76] Kang WS,Chung KH,Chung JH,et al.Antiplatelet activity of green tea catechins is mediated by inhibition of cytoplasmic calcium increase[J].J Cardiovasc Pharmacol,2001,38(6):875-884.
[77] Serafini M,Laranjinha JA,Almeida LM,et al.Inhibition of human LDL lipid peroxidation by phenol-rich beverages and their impact on plasma total antioxidant capacity in humans[J].J Nutr Biochem,2000,11(11-12):585-590.
[78] Murakami T,Ohsato K.Dietary green tea intake preserves and improves arterial compliance and endothelial function[J].J Am Coll Cardiol,2003,41(6s1):271.
[79] Kim W,Jeong MH,Cho SH,et al.Effect of green tea consumption on endothelial function and circulating endothelial progenitor cells in chronic smokers[J].Circ J,2006,70(8):1052-1057.
[80] Oyama J,Maeda T,Kouzuma K,et al.Green tea catechins improve human forearm endothelial dysfunction and have antiatherosclerotic effects in smokers[J].Circ J,2010,74(3):578-588.
[81] Wang ZM,Zhou B,Wang YS et al.Black and green tea consumption and the risk of coronary artery disease:a meta-analysis[J].Am J Clin Nutr,2011,93(3):506-515.
[82] Nagaya N,Yamamoto H,Uematsu M,et al.Green tea reverses endothelial dysfunction in healthy smokers[J].Heart,2004,90(12):1485-1486.
[83] Pearson DA,Frankel EN,Aeschbach R,et al.Inhibition of endothelial cell mediated low-density lipoprotein oxidation by green tea extracts[J].J Agric Food Chem,1998,46:1445-1449.
[84] Sung H,Min WK,Lee W,et al.The effects of green tea ingestion over 4 weeks on atherosclerotic markers[J].Ann Clin Biochem,2005,42(Pt 4):292-297.
[85] Tang FY,Meydani M.Green tea catechins and vitamin E inhibit angiogenesis of human microvascular endothelial cells through suppression of IL-8 production[J].Nutr Cancer,2001,41(1-2):119-125.
[86] Vlachopoulos C,Alexopoulos N,Dima I,et al.Acute effect of black and green tea on aortic stiffness and wave reflections[J].J Am Coll Nutr,2006,25(3):216-223.
[87] Sano J,Inami S,Seimiya K,et al.Effects of green tea intake on the development of coronary artery disease[J].Circ J,2004,68(7):665-670.
[88] Hollman PC,Tijburg LB,Yang CS.Bioavailability of flavonoids from tea[J].Crit Rev Food Sci Nutr,1997,37(8):719-738.
[89] Meng X,Sang S,Zhu N,et al.Identification and characterization of methylated and ring-fission metabolites of tea catechins formed in humans,mice,and rats[J].Chem Res Toxicol,2002,15(8):1042-1050.
[90] Manach C,Williamson G,Morand C,et al.Bioavailability and bioefficacy of polyphenols in humans.I.Review of 97 bioavailability studies[J].Am J Clin Nutr,2005,81(1 Suppl):230S-242S.
[91] Manning J,Roberts JC.Analysis of catechin content of commercial green tea products[J].J Herb Pharmacother,2003,3(3):19-32.
[92] Nakagawa K,Okuda S,Miyazawa T.Dose-dependent incorporation of tea catechins,(-)-epigallocatechin-3-gallate and(-)-epigallocatechin,into human plasma[J].Biosci Biotechnol Biochem,1997,61(12):1981-1985.
[93] Chow HH,Hakim IA,Vining DR,et al.Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of Polyphenon E in healthy individuals[J].Clin Cancer Res,2005,11(12):4627-4633.